149 results

• Mounjaro Side Effects Led to Emergency Surgery, Lawsuit Alleges

  September 24, 2025

  Irvin Jackson

  A lawsuit over Mounjaro side effects claims the diabetes drug led to a bowel obstruction resulting in permanent injuries.

• GLP-1 Side Effects May Increase Kidney Cancer Risks: Study

  September 3, 2025

  Irvin Jackson

  New research suggests GLP-1 drugs may lower the risk of certain cancers, but could also raise the likelihood of developing kidney cancer.

• MDL Sought for GLP-1 NAION Lawsuits Against Ozempic, Wegovy, Mounjaro Manufacturers

  August 29, 2025

  Irvin Jackson

  Eli Lilly seeks to consolidate all GLP-1 vision loss lawsuits into a new MDL, and assign them to the same court where the drugs' gastroparesis injury cases are being held.

• Mounjaro Stomach Paralysis Risks Higher Than Other Diabetes Drugs, Review Finds

  August 26, 2025

  Irvin Jackson

  Chinese researchers have compiled an evolving review of diabetes drug side effects, which links Mounjaro to the highest risk of gastrointestinal problems, including stomach paralysis.

• GLP-1 Vision Loss Risks Extend Beyond Type 2 Diabetics and Ozempic Users, Study Warns

  August 6, 2025

  Irvin Jackson

  New research suggests that vision problems are not restricted to just Ozempic, but may be a risk faced by all GLP-1 medication users.

• Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries

  July 29, 2025

  Irvin Jackson

  A Mounjaro lawsuit claims an Ohio woman suffered severe injuries due to a lack of warnings about the risks of stomach paralysis.

• Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators

  July 15, 2025

  Irvin Jackson

  U.K. health regulators are urging users of drugs like Ozempic and Mounjaro to report cases of acute pancreatitis as part of an ongoing genetic investigation.

• NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss

  July 10, 2025

  Irvin Jackson

  Novo Nordisk is facing a lawsuit alleging it failed to adequately warn about the risk of vision loss from Ozempic, including cases of NAION (non-arteritic anterior ischemic optic neuropathy).

• Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study

  June 23, 2025

  Irvin Jackson

  A new study links the use of Ozempic and Wegovy to an increased risk of age-related macular degeneration that could cause vision loss.

• Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court

  June 18, 2025

  Irvin Jackson

  At least 21 Ozempic and Wegovy lawsuits have been filed in New Jersey state court, involving allegations that users were left with vision loss from NAION after using the popular diabetes and weight loss drugs.